E-LIB Suche - Ergebnisse für: Thavasu, P.

1

PO-498 Quantifying the dynamics of acquired treatment resis..:

Acar, A. ; Nichol, D. ; Thavasu, P....
ESMO Open. 3 (2018) - p. A217 , 2018

Link: https://doi.org/10.1136/..

2

Titration of signalling output: insights into clinical comb..:

Stewart, A. ; Thavasu, P. ; de Bono, J.S..
Annals of Oncology. 26 (2015) 7 - p. 1504-1510 , 2015

Link: https://doi.org/10.1093/..

3

AKT inhibition synergistically enhances growth-inhibitory e..:

Puglisi, M. ; Thavasu, P. ; Stewart, A....
Lung Cancer. 85 (2014) 2 - p. 141-146 , 2014

Link: https://doi.org/10.1016/..

4

Phase I Study of Bryostatin 1: Assessment of Interleukin 6 ..:

Philip, P. A. ; Rea, D. ; Thavasu, P....
JNCI Journal of the National Cancer Institute. 85 (1993) 22 - p. 1812-1818 , 1993

Link: https://doi.org/10.1093/..

5

Multiple myeloma: An immunoclinical study of disease and re..:

Thavasu, P. W. ; Ganjoo, R. K. ; Maidment, S. A....
Hematological Oncology. 13 (1995) 2 - p. 69-82 , 1995

Link: https://doi.org/10.1002/..

6

Measuring cytokine levels in blood:

Thavasu, P.W. ; Longhurst, S. ; Joel, S.P...
Journal of Immunological Methods. 153 (1992) 1-2 - p. 115-124 , 1992

Link: https://doi.org/10.1016/..

7

Evaluation of the combination of the dual m-TORC1/2 inhibit..:

Wong Te Fong, A-C ; Thavasu, P ; Gagrica, S...
Oncotarget, 2017, 8 (69), pp. 113874 - 113884. , 2018

Link: https://repository.icr.a..

8

A study of PD-L1 expression in KRAS mutant non-small cell l..:

Minchom, A ; Thavasu, P ; Ahmad, Z...
PloS one, 2017, 12 (10), pp. e0186106 - ?. , 2017

Link: https://repository.icr.a..

9

Titration of signalling output: insights into clinical comb..:

Stewart, A ; Thavasu, P ; de Bono, JS.
Annals of oncology : official journal of the European Society for Medical Oncology, 2015, 26 (7), pp. 1504 - 1510. , 2016

Link: https://repository.icr.a..

10

Insights into significance of combined inhibition of MEK an..:

Broutin, S ; Stewart, A ; Thavasu, P...
British journal of cancer, 2016, 115 (5), pp. 549 - 552. , 2016

Link: https://repository.icr.a..

11

Titration of signalling output: insights into clinical comb..:

Stewart, A ; Thavasu, P ; de Bono, J. S.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478974/. , 2015

Link: http://www.ncbi.nlm.nih...

12

Association of creatine kinase and skin toxicity in phase I..:

Moreno Garcia, V ; Thavasu, P ; Blanco Codesido, M...
https://www.repository.cam.ac.uk/handle/1810/310738. , 2012

Link: https://www.repository.c..

13

Association of creatine kinase and skin toxicity in phase I..:

Moreno Garcia, V ; Thavasu, P ; Blanco Codesido, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504946. , 2012

Link: http://www.ncbi.nlm.nih...

14

Combination antiangiogenesis therapy with marimastat, capto..:

Jones, P H ; Christodoulos, K ; Dobbs, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364746. , 2004

Link: http://www.ncbi.nlm.nih...

15

The Association of PI3 Kinase Signaling and Chemoresistance..:

Carden, Craig P ; Stewart, Adam ; Thavasu, Parames...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630857/. , 2012

Link: http://www.ncbi.nlm.nih...